BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19337549)

  • 1. Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease.
    Graham MR; Evans P; Davies B; Baker JS
    Vasc Health Risk Manag; 2008; 4(6):1361-71. PubMed ID: 19337549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology.
    Graham MR; Evans P; Thomas NE; Davies B; Baker JS
    Am J Cardiovasc Drugs; 2009; 9(6):371-81. PubMed ID: 19929035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.
    Lin E; Wexler TL; Nachtigall L; Tritos N; Swearingen B; Hemphill L; Loeffler J; Biller BM; Klibanski A; Miller KK
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):430-8. PubMed ID: 22315983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Cardiovascular Risk With Arterial Stiffness in Patients with Nonfunctioning Pituitary Adenoma.
    Çağır Y; Altay M; Çağır BB; Çakal E; Akkan T; Yıldız C; Ünsal Y; Dağdeviren M; Beyan E
    Endocr Pract; 2018 Sep; 24(9):815-822. PubMed ID: 29975581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile.
    Filchenko I; Korostovtseva L; Bochkarev M; Boyarinova M; Alieva A; Rotar O; Sviryaev Y; Tsoi U; Grineva E
    Growth Horm IGF Res; 2021; 57-58():101395. PubMed ID: 33962370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial stiffness and function in end-stage renal disease.
    London GM; Marchais SJ; Guerin AP
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):202-9. PubMed ID: 15216492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse wave velocity as an index of arterial stiffness: a comparison between newly diagnosed (untreated) hypertensive and normotensive middle-aged Malay men and its relationship with fasting insulin.
    Ngim CA; Abdul Rahman AR; Ibrahim A
    Acta Cardiol; 1999 Oct; 54(5):277-82. PubMed ID: 10596307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
    Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurements.
    Katsumata N
    Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):209-215. PubMed ID: 28516748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.